Efficacy and Safety Study of F373280

Summary

The purpose of this study is to assess the efficacy of F373280 on the maintenance of normal cardiac rhythm after direct electric cardioversion in patients with persistent atrial fibrillation and cardiac failure.

Timeline

Start

2013-04

Primary completion

2017-04-03

Completion

2017-06-21

Outcome

Missed primary endpoint

registry analysis (superiority test); F373280 vs Placebo; p = 0.5749; Hazard Ratio (HR) 1.14 (95% CI 0.71 to 1.85); Log Rank NCT01831856 ↗

Drugs

Indications